Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study

• Main Authors: Luigi Gargiulo (Author), Luciano Ibba (Author), Alessandra Narcisi (Author), Silvia Giordano (Author), Carlo A. Maronese (Author), Fabrizio Martora (Author), Federica Repetto (Author), Giovanni Paolino (Author), Anna Balato (Author), Martina Burlando (Author), Paolo Dapavo (Author), Valentina Dini (Author), Claudio Guarneri (Author), Angelo V. Marzano (Author), Matteo Megna (Author), Santo R. Mercuri (Author), Antonio Costanzo (Author), Mario Valenti (Author)
• Format: Book
• Published: Mattioli1885, 2024-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Psoriasis and hidradenitis suppurativa (HS) are chronic inflammatory diseases with significant overlap in their immunologic pathways, which involve cytokines such as tumor necrosis factor-alfa, interleukin (IL)-17, and IL-23. Current treatment options for HS are limited, as only adalim...